Insulet (PODD) Current Deferred Tax Assets (2011 - 2012)
Insulet's (PODD) quarterly Current Deferred Tax Assets came in at $500000.0 in Q4 2012, down 44.44% on a YoY basis from $900000.0 in Q1 2012, and down 44.44% quarter-over-quarter from $900000.0 in Q3 2012.
Powered by 
Analysis
Insulet (PODD) Current Deferred Tax Assets (2011 - 2012) Analysis & Trends
Insulet (PODD) has reported Current Deferred Tax Assets for 2 consecutive years, with $500000.0 the latest figure, recorded in Q4 2012.
- For the quarter ending Q4 2012, Current Deferred Tax Assets fell 44.44% year-over-year to $500000.0; the trailing twelve-month figure through Dec 2012 stood at $500000.0 (down 44.44% YoY), and the FY2012 full-year result was $500000.0, down 44.44% from the prior year.
- Current Deferred Tax Assets eased to $500000.0 in Q4 2012 per PODD's latest filing, from $900000.0 in the prior quarter.
- Across five years, Current Deferred Tax Assets topped out at $900000.0 in Q4 2011 and bottomed at $500000.0 in Q4 2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.76 Bn | 175.16 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn |
| 3 | Medtronic | 117.20 Bn | 108.39 Bn | 6.34 Bn |
| 4 | Stryker | 104.01 Bn | 100.53 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.80 Bn | 45.55 Bn | 1.35 Bn |
| 7 | Alcon | 33.03 Bn | 31.58 Bn | 1.68 Bn |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn |
| 10 | Insulet | 9.35 Bn | 8.82 Bn | 562.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2012 | 500,000.00 |
| Sep 30, 2012 | 900,000.00 |
| Jun 30, 2012 | 900,000.00 |
| Mar 31, 2012 | 900,000.00 |
| Dec 31, 2011 | 900,000.00 |